Correlation Between Rezolute and ARCA Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rezolute and ARCA Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and ARCA Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and ARCA Biopharma, you can compare the effects of market volatilities on Rezolute and ARCA Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of ARCA Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and ARCA Biopharma.

Diversification Opportunities for Rezolute and ARCA Biopharma

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Rezolute and ARCA is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and ARCA Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARCA Biopharma and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with ARCA Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARCA Biopharma has no effect on the direction of Rezolute i.e., Rezolute and ARCA Biopharma go up and down completely randomly.

Pair Corralation between Rezolute and ARCA Biopharma

Given the investment horizon of 90 days Rezolute is expected to generate 0.63 times more return on investment than ARCA Biopharma. However, Rezolute is 1.6 times less risky than ARCA Biopharma. It trades about 0.06 of its potential returns per unit of risk. ARCA Biopharma is currently generating about -0.02 per unit of risk. If you would invest  188.00  in Rezolute on September 23, 2024 and sell it today you would earn a total of  251.00  from holding Rezolute or generate 133.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy84.31%
ValuesDaily Returns

Rezolute  vs.  ARCA Biopharma

 Performance 
       Timeline  
Rezolute 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Rezolute is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
ARCA Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ARCA Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, ARCA Biopharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Rezolute and ARCA Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rezolute and ARCA Biopharma

The main advantage of trading using opposite Rezolute and ARCA Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, ARCA Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will offset losses from the drop in ARCA Biopharma's long position.
The idea behind Rezolute and ARCA Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume